MedFuture-B (6132.HK) surged 8% in Hong Kong trading to HK$38.60, with turnover of HK$19.53 million.

The stock reached a high of HK$40.20 today, extending its rebound since listing. It debuted on the Main Board on June 23 at an issue price of HK$81.80, then tumbled more than 57% on its first day to close at HK$35.26, making it the worst-performing new issue this year. Some analysts say investment logic in the HK 18A sector is shifting, with capital prioritizing cash flow and commercial certainty, leading to corrections in high valuation expectations.